ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,155 | -31.0% | 5,900 | -15.0% | 0.00% | – |
| Q2 2023 | $46,581 | -24.5% | 6,942 | -0.7% | 0.00% | – |
| Q1 2023 | $61,722 | +21.9% | 6,990 | +5.5% | 0.00% | – |
| Q4 2022 | $50,638 | -32.5% | 6,628 | -37.3% | 0.00% | – |
| Q3 2022 | $75,000 | -73.8% | 10,566 | -70.1% | 0.00% | -100.0% |
| Q2 2022 | $286,000 | -57.6% | 35,310 | -27.3% | 0.00% | 0.0% |
| Q1 2022 | $674,000 | -50.4% | 48,592 | +0.3% | 0.00% | -50.0% |
| Q4 2021 | $1,359,000 | +2.0% | 48,435 | +23.6% | 0.00% | -33.3% |
| Q3 2021 | $1,332,000 | -13.1% | 39,202 | +4.5% | 0.00% | 0.0% |
| Q2 2021 | $1,533,000 | +38.0% | 37,523 | +35.9% | 0.00% | +50.0% |
| Q1 2021 | $1,111,000 | -23.6% | 27,617 | +12.2% | 0.00% | -33.3% |
| Q4 2020 | $1,455,000 | +20.2% | 24,608 | -1.1% | 0.00% | 0.0% |
| Q3 2020 | $1,210,000 | +9.3% | 24,872 | +8.7% | 0.00% | 0.0% |
| Q2 2020 | $1,107,000 | +371.1% | 22,880 | +170.2% | 0.00% | +200.0% |
| Q1 2020 | $235,000 | – | 8,468 | +846700.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |